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HNF-4αHepatocyte nuclear factor-4 alpha (HNF-4α) is a member of the nuclear receptor superfamily with important
roles in hepatic metabolism. Fasting induces the cAMP/protein kinase A (PKA)-signaling pathway. The
mechanisms whereby cAMP regulates HNF-4α transcriptional activity are incompletely understood. We
have therefore investigated the role of cAMP/PKA in regulation of HNF-4α in COS-1 cells and the hepatoma
HepG2 cell line. cAMP/PKA inhibited the transcriptional activity of HNF-4α in COS-1 cells, whereas a
stimulatory effect was observed in HepG2 cells. The cAMP-induced inhibition of HNF-4α in COS-1 cells was
counteracted by overexpression of the nuclear receptor coactivator PGC-1α, and cAMP/PKA-dependent
induction of the PGC1A gene in HepG2 cells seems to explain the cell speciﬁc differences. This was further
supported by knock-down of PGC-1α in HepG2 cells, which abolished the stimulatory effect of PKA on HNF-
4α transcriptional activity. Similar to the cAMP/PKA-mediated regulation of HNF-4α, overexpression of the
cAMP-response element binding protein (CREB) inhibited the transcriptional activity of HNF-4α in COS-1
cells, regardless of cAMP/PKA activation and CREB phosphorylation. Moreover, activation of CREB by cAMP/
PKA further stimulated HNF-4α transactivation in HepG2 cells. cAMP induced the expression of the HNF-4α
target genes PCK1 and G6Pase in these cells. In conclusion, our results suggest that the level of PGC-1α
determines whether the cAMP/PKA-pathway overall stimulates or inhibits HNF-4α transcriptional
activation.P, cyclic adenosine monopho-
n; GAPDH, glyceraldehyde-3-
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Glucagon is a key regulator of metabolism by stimulating the cyclic
adenosine monophosphate (cAMP)/protein kinase A (PKA) signaling
pathway,which in turnmodulates transcription of genes that control key
metabolic processes. Several cAMP responsive transcription factors have
been characterized [1], including the well-described element binding
protein (CREB) which is phosphorylated and activated by PKA [2].
Nuclear receptors (NRs) comprise a large family of ligand-
dependent transcription factors that play important roles in cell
differentiation, reproduction, homeostasis and disease [3,4]. The liver-
enriched nuclear receptor hepatocyte nuclear factor (HNF)-4α
(NR2A1) is a highly conserved and constitutively active member of
the NR family [5]. It has been shown that HNF-4α is expressed in liver,
pancreas, kidney and intestine [5–7], and it binds to as many as ∼12%
of 13,000 examined promoters in human hepatocytes and pancreatic
islets, emphasizing the versatile role of this nuclear receptor in generegulation [8]. HNF-4α is required for embryogenesis and develop-
ment [9] and plays a critical role in hepatic glucose and lipid
metabolism [10–12]. Mutations in HNF-4α result in impaired insulin
secretion and a monogenic form of diabetes [13]. A better under-
standing of the mechanisms that regulate HNF-4α-mediated tran-
scription may lead to novel treatments for a variety of diseases [14].
The transcriptional activity of HNF-4α is modulated by posttrans-
lational modiﬁcations, and it contains 21 serine, six threonine and
seven tyrosine residues where phosphorylation may potentially alter
its DNA binding activity and transactivation potential [15]. PKA and
p38 mitogen-activated protein kinase mediate speciﬁc phosphoryla-
tions of HNF-4α [16,17]. The transcriptional activity of HNF-4α also
depends on its interactions with different nuclear receptor coregula-
tors, RNA polymerase II, and members of the basal transcription
machinery. Nuclear receptor coactivators and corepressors are diverse
molecules that modulate the gene transcriptionmediated by NRs [18–
20]. The peroxisome proliferator-activated receptor gamma coacti-
vator (PGC)-1α, the cAMP-response-element-binding protein/p300-
interacting protein, and the members of the p160 steroid receptor
coactivator (SRC) family [SRC-1, SRC-2 and SRC-3], have been
reported to interact with HNF-4α [21–23]. The mechanisms control-
ling the activity of HNF-4α coregulators are only partly elucidated, but
several studies have reported that posttranslational modiﬁcations
such as sumoylation, ubiquitination, phosphorylation and acetylation
elicit speciﬁc effects on their ability to activate NRs and to interact
with other transcription factors [24–26].
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processes involved in energy production and utilisation, including
adaptive thermogenesis, mitochondrial biogenesis, glucose uptake
and metabolism in muscle, and skeletal muscle ﬁbre-type switching
[27]. In the liver, PGC-1α is induced during fasting and stimulates
hepatic de novo glucose synthesis (gluconeogenesis), at least in part
through its stimulatory effect on HNF-4α [28,29]. Fasting has also
been observed to alter the expression of bile acid transporter in
hepatocytes via PGC-1α and HNF-4α [30]. Target genes of HNF-4α/
PGC-1α include phosphoenolpyruvate carboxykinase (PCK1) and
glucose-6-phosphatase (G6Pase), two rate-limiting enzymes in
gluconeogenesis [10,31]. Moreover, the transcription factor CREB
also contributes to the regulation of glucose homeostasis [29]. CREB is
phosphorylated by the cAMP/PKA signaling pathway, and phosphor-
ylated CREB stimulates PCK1 transcription via a CREB response
element in the PCK1 promoter. In addition, PKA-mediated phosphor-
ylation of CREB stimulates the expression of PGC-1α via a CREB
response element in the PGC-1α promoter, and PGC-1α is one of few
coactivators whose activity is modulated through regulated expres-
sion of its gene [18].
In this paper we explored the role of cAMP/PKA signaling in
regulation of HNF-4α transcriptional activity,with an emphasis on PGC-
1α andCREB.Using twodifferent cell lines, thehumanhepatomaHepG2
cells and COS-1 cells, we demonstrate cell-speciﬁc effects of the cAMP/
PKA signaling pathway, and that the cAMP/PKA-mediated regulation of
HNF-4α transcriptional activity depends on the coactivator context. Our
observations in HepG2 cells are in line with the model in which PKA-
mediated activation of CREB enhances HNF-4α transcriptional activity
via induction of the PGC-1α gene. Thus, our observations in COS-1 cells
may be largely ascribed to a lack of PGC-1α induction.
2. Materials and methods
2.1. Plasmid constructs
The pGV.B2-HNF-4-tk-luc reporter plasmid for HNF-4α and the
expression plasmid pcDNA3.1-HNF-4α encoding wild-type HNF-4α
were kindly provided by Dr. A Fukamizu (Tsukuba, Ibaraki, Japan) and
Dr. J Ladias (Boston, MA), respectively. The pGV.B2-HNF-4-tk-luc
reporter plasmid is a heterologous luciferase reporter containing eight
copies of a HNF-4 binding sequence from the mouse transthyretin
promoter fused to a minimal TK promoter. The expression plasmid
pcDNA-PGC 797 encoding wild-type PGC-1α was generously provided
by Dr. D. Kelly (St. Louis, MI). The expression plasmid pCMV5-Cα
encoding the catalytic subunit of PKA was a gift from Dr. G.S. McKnight
(Washington, SA). The expression plasmid RSV-CREB encoding wild-
type CREB was a gift from Dr. R.H. Goodman (Portland, OR). The empty
vector pCMV5 was purchased from Invitrogen (Carlsbad, CA).
2.2. Cell culture and transfection experiments
African monkey kidney cells (COS-1) were cultured in Dulbecco's
Modiﬁed Eagle's Medium, and human hepatoma cells (HepG2) were
cultured in Eagle's Minimum Essential Medium containing non-
essential amino acids and sodium pyruvate (BioWhittaker). Both
media were supplemented with 10% fetal bovine serum, 2 mM L-
glutamine (BioWhittaker) in 0.85% NaCl solution, 100 units of
penicillin and 100 μg of streptomycin per ml. Cells were transiently
transfected using SuperFect (Qiagen) according to the manufacturer's
recommendations. Transfected cells were washed once with PBS and
harvested 48 h after transfection. Cells were lysed in a buffer
containing 25 mM TAE, pH 7.8, 2 mM DTT, 1 mM EDTA, 10% glycerol
and 1% Titron-X. Luciferase assays were performed using the
luciferase assay kit (BioThema AB, Sweden). All experiments were
performed in triplicate.2.3. Transfection of siRNA
siGENOME SMARTpool of PGC-1α siRNAs (Dharmacon) that
speciﬁcally targets PGC-1α mRNA, and a non-speciﬁc scramble
control (Scr) siRNA (5'-UGCCCAAGCACCUUAGUGC-dTdT-3', Eurogen-
tec, Herstal, Belgium) were employed. HepG2 cells were seeded in
growth medium in 24-well plates or 90 mm petri dishes 1 day before
transfection. siRNAs (40 nM) were transfected twice using TransIT-
TKO® Transfection Reagent (Mirus Bio LLC, WI) according to the
manufacturer's protocol. The second transfection was performed 24 h
after the ﬁrst. For the studies of reporter gene expression, siRNA
transfected cells were further transfected with plasmid DNAs using
Lipofectamine 2000 (Invitrogen, CA).
2.4. Quantitative RT-PCR
Total RNA from transfected HepG2 and COS-1 cells was isolated
using theRNeasyMini Kit (Qiagen,MD) according to themanufacturer's
protocol. Synthesis of cDNA from the total RNA was then performed
using Transcriptor First Strand cDNA Synthesis Kit, followed by
quantitative real-time RT-PCR using the LightCycler-Master SYBR
Green I Kit in the LightCycler 480 rapid thermal cycler system (Roche
Molecular Biochemicals). Target expression was quantiﬁed relative to a
constitutive control gene, porphobilinogen deaminase (PBGD) or TATA-
binding protein (TBP). The following forward (F) and reverse (R)
primers were used for ampliﬁcation: F (PGC-1α); 5'-AATGTGT-
CTCCTTCTTGTTCTT-3' and R (PGC-1α); GGTGTCTGTAGTGGCTTGA-3',
F (PGC-1α in siRNA experiment); 5'-CCCATTTGAGAACAAGACTAT-3'
and R (PGC-1α in siRNA experiment); 5'-GGTTATCTTGGTTGGCTTT-3'; F
(PBGD); 5'-CGGAAGAAAACAGCCCAAAGA-3' and R (PBGD); 5'-TGAA-
GCCAGGAGGAAGCACAGT-3', and F (TBP); 5'-TTCGGAGAGTTCTGG-
GATTGTA-3' and R (TBP); 5'-TGGACTGTTCTTCACTCTTGGC-3'.
Standards in the range of 0.01–100 pg/μl were used. Negative controls
were prepared by replacing the mRNA template with PCR-grade H2O.
The RT-PCR included a 20-min reverse transcription step at 61 °C, a 5-s
denaturation step at 95 °C, and then 45 cycles consisting of denaturation
at95 °C for 5 s, annealing at54 °C for 5 s, and anextensionphase at72 °C
for 18 s. Fluorescence was measured at the end of the 72 °C extension
phase. The quality of the RT-PCR products was controlled by melting
point curve analysis. Mean fold difference in mRNA PGC-1α expression
in HepG2 cells compared to COS-1 cells was calculated using the
crossingpoint (CP) for each sample (triplicate) and theefﬁciency (Eff) of
the transcript, using the formula EffPGC-1αΔCP /EffPBGDΔCP . For real-time PCR
analyses in Fig. 6, we used LightCycler480 Probes Master (Roche) and
speciﬁc Universal ProbeLibrary (UPL) probes; #3 for HNF4α, #42 for
PGC-1α, #53 for PCK1 and #67 for G6Pase in duplex with UPL Human
TBP Gene Assay (Roche). Gene speciﬁc primers were as following;
F (HNF4α); 5'-ATTGACAACCTGTTGCAGGA-3' and R (HNF4α); 5'-CGTT-
GGTTCCCATATGTTCC-3', and F (PGC-1α); 5'-AAAAGCTTGACTGGCGT-
CAT-3' and R (PGC-1α); 3'-ACCAACCAGAGCAGCACAC-3', and F (PCK1);
5'-AAGTGCTTTGCTCTCAGGATG-3' and R (PCK1); 5'-GGGTTGGTTA-
TACCCAGAATCA-3', and F (G6Pase); 5'-GCTGCTCATTTTCCTCATCAA-3'
and R (G6Pase); 5'-TTCTGTAACAGCAATGCCTGA-3'.
2.5. Western blot analysis
Cells were lysed in a buffer containing 50 mM Tris–HCl, pH 7.5,
200 mMNaCl, 5 mMEDTA, 1% Igepal (NP40), 1 μg/ml aprotinin, 5 mM
N-ethylmaleimide, 100 nM sodium orthovanate and 0.2 mM PMSF,
supplemented with Complete Mini EDTA-free protease inhibitor
tablets (Roche Applied Science). The cell lysates were subjected to
SDS-PAGE (6 or 10%) and Western blotting. In immunoblotting, the
Western membrane was ﬁrst blocked with PBS (0.1% Tween)
containing 5% (w/v) dried skimmed milk for 1 h. After multiple
washes in PBS-Tween, the membrane was incubated with primary
antibody for 1 h and secondary antibody for 30 min. For detection of
Fig. 1. Effects of PKA on HNF-4α-dependent gene transcription in COS-1 and HepG2
cells. COS-1 (A, B) and HepG2 (C, D) cells were transfected with the HNF-4-tk-luc
reporter construct (0.6 μg) and expression plasmids encoding HNF-4α (0.05 μg), PKA-
Cα (0.1 μg), and PGC-1α (0.5 μg). 8-CPT-cAMP (300 μM) (cAMP) was added 3 h after
transfection. The cells were lysed 48 h after transfection and subjected to luciferase
assays as described in Materials and Methods. Luciferase activity is presented as the
mean±SD of at least two independent experiments with triplicate transfections.
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4α was detected using goat polyclonal anti-HNF-4α IgG (C-19, Santa
Cruz Biotechnology). CREB and Serine 133-speciﬁc phosphorylated
CREB (PCREB) were detected using rabbit polyclonal anti-CREB
(Upstate) and anti-PCREB (Cell Signaling) antibodies, respectively.
GAPDH was detected using mouse monoclonal anti-GAPDH antibody
(Chemicon International). Goat anti-rabbit IgG (Pierce) or donkey
anti-mouse IgG (Santa Cruz) were employed as secondary antibodies.
Proteins were visualized using the enhanced SuperSignal(R) West
Pico Chemiluminescent Substrates (Pierce), and the ChemiDoc XRS
System with Quantity One(R) 1-D Analysis Software (Bio-Rad).
3. Results
3.1. cAMP-mediated regulation of HNF-4α transcriptional activity
It has previously been reported that PKA phosphorylates HNF-4α
in rat liver, and the phosphorylation was found to reduce HNF-4α
transcriptional activity in COS cells [16]. In order to examine how PKA
regulates the transcriptional activity of HNF-4α in more detail, HepG2
and COS-1 cells were transiently transfected with expression
plasmids encoding HNF-4α and the catalytic subunit of PKA (PKA-
Cα), together with the HNF-4-tk-luc reporter gene. Cells were also
treated with the cAMP analog 8-CPT-cAMP. As shown previously, we
observed a marked reduction in HNF-4α-mediated transcriptional
activity upon activation of the cAMP/PKA signaling pathway in COS-1
cells (Fig. 1A). In contrast, exposure to 8-CPT-cAMP or overexpression
of PKA-Cα in HepG2 cells enhanced the HNF-4α transactivation
(Fig. 1C), suggesting that the cAMP/PKA-mediated regulation of HNF-
4α depends on the cell type.
Based on these ﬁndings, we hypothesized that HepG2 cells contain
one or more transcription factors that are involved in the cAMP/PKA-
mediated regulation of HNF-4α. It is well known that PKA phosphor-
ylates the transcription factor CREB, which, in turn, stimulates the
expression of PGC-1α via a CREB response element in the PGC-1α
promoter [29]. In order to test to what degree the level of PGC-1α
modulated cAMP/PKA-mediated regulation of HNF-4α, cells were
also transfected with PGC-1α expression plasmid. In absence of HNF-
4α overexpression, PGC-1α enhanced luciferase activity only in
HepG2 cells (Fig. 1A and C), likely due to a higher endogenous level of
HNF-4α in this cell line. Accordingly, when HNF-4α was also
overexpressed, PGC-1α was a potent coactivator of HNF-4α-depen-
dent transcriptional activity in both HepG2 and COS-1 cells (Fig. 1B
and D). Interestingly, overexpression of PGC-1α in COS-1 cells
counteracted the inhibitory effect of cAMP/PKA on HNF-4α tran-
scriptional activity. We also noted that PGC-1α overexpression in
HepG2 cells led to a further increase in HNF-4α activity, and that
cAMP/PKA potentiated this stimulatory effect of PGC-1α.
In order to compare the expression levels of PGC-1α in COS-1 and
HepG2 cells, we performed western blot analyses. A higher endog-
enous level of PGC-1α protein was detected in HepG2 cells, with
barely detectable endogenous PGC-1α in COS-1 cells (Fig. 2A). As
expected, endogenous HNF-4α protein was only detected in HepG2
cells. In COS-1 cells, we observed that the increase in HNF-4α protein
with HNF-4α overexpression was not as high after coexpression with
PGC-1α. Quantitative real-time RT-PCR conﬁrmed that the PGC-1α
mRNA expression was substantially higher in HepG2 cells than in
COS-1 cells (Fig. 2B). Moreover, in HepG2 cells, treatment with a
cAMP analog or overexpression of PKA-Cα increased the PGC-1α
mRNA level (Fig. 2B). Overexpression of PGC-1α resulted in a
comparable expression level of PGC-1α in the two cell types
(Fig. 2C). To further examine whether the cAMP-mediated stimula-
tion of HNF-4α-dependent transcriptional activity depends on PGC-
1α, we performed knock-down of PGC-1α in HepG2 cells using
siRNAs. As hypothesized, knock-down of PGC-1α signiﬁcantly
reduced HNF-4α-mediated transactivation in HepG2 cells (Fig. 3A)through reduction of PGC-1αmRNA (Fig. 3B). Moreover, we observed
that knock-down of PGC-1α abolished the PKA-mediated stimulation
of HNF-4α-dependent transcriptional activity, conﬁrming that cAMP/
PKA-mediated regulation of HNF-4α depends on the presence of
coactivator PGC-1α.
3.2. CREB-mediated regulation of HNF-4α transcriptional activity
Since the cAMP/PKA-induced regulation of HNF-4α could be
mediated by the transcription factor CREB, and the expression of PGC-
1α is known to be stimulated by activation of CREB [18], we next sought
to test whether CREB could modulate HNF-4α transactivation differen-
tially in COS-1 and HepG2 cells. We found no signiﬁcant effect of CREB
overexpression in COS-1 cells in the absence of HNF-4α overexpression
(Fig. 4A). In COS-1 cells that were transiently transfected with HNF-4α
expression plasmid, we found that CREB overexpression reduced HNF-
4α transcriptional activity similar to the observation with cAMP/PKA
(Fig. 4B). Treatment with cAMP analog together with CREB over-
expression further suppressed the HNF-4α-dependent transcriptional
activity. Conversely, in HepG2 cells CREB stimulated transcriptional
activity both with and without overexpressed HNF-4α, and cAMP/PKA
further enhanced this effect (Fig. 4C and D).
Fig. 2. Cell speciﬁc expression of PGC-1α. (A) HepG2 and COS-1 cells were cultured and
left untreated, or transfected with PGC-1α (0.5 μg) or HNF-4α (0.05 μg) expression
plasmids. The cells were lysed 48 h after transfection and subsequently subjected to
SDS-PAGE and Western blotting using anti-PGC-1α (1:250 dilution), anti-HNF-4α
(1:500 dilution), and anti-GAPDH (1:1000 dilution) antibodies. (B) HepG2 and COS-1
cells were cultured and left untreated (control), treated with 8-CPT-cAMP (cAMP)
(150 μM), or transfected with the expression plasmid encoding PKA-Cα (0.1 μg) as
indicated. The cells were lysed in TRIzol 48 h after transfection and total RNA was
puriﬁed from the cell lysates. Quantitation of PGC-1α mRNA levels was performed as
described in Materials and methods. (C) Fold difference of PGC-1α mRNA levels was
calculated between HepG2 and COS-1 cells which both were untransfected or
transfected with expression plasmid encoding PGC-1α (0.5 μg). The results are
presented as ΔΔCP±SD of two independent experiments performed in triplicate.
Fig. 3. PGC-1α siRNA inhibited PKA-mediated stimulation of HNF-4α-dependent
transcription. (A) HepG2 cells were transfected with scramble (Src) control siRNAs
(40 nM) or siRNA speciﬁcally targeting PGC-1α (40 nM) as described in Materials and
methods. The cells were allowed to grow 48 h before transfection with the HNF-4-tk-luc
reporter construct (0.7 μg) and expression plasmids encoding HNF-4α (0.05 μg) and PKA-
Cα (0.05 μg) by using Lipofectamine 2000. The cells were lysed 30 h after the plasmid
transfections. Luciferase activity is presented as themean±SDof triplicate transfectionsand
is representative of three independent experiments. (B) Relative expression levels of PGC-
1α in HepG2 cells transfectedwith Scr and PGC-1α siRNAs as described in A. Total RNAwas
isolated from the transfected cells after 78 h. PGC-1αmRNA was quantiﬁed using primers
and real-time RT-PCR as described in Materials and methods. The ﬁgure shows the
normalized values between PGC-1α and TBP expression levels, where the scale is adjusted
100-fold to avoid decimals. The results are presented as themean±SDof triplicate samples.
Fig. 4. The effect of PKA/CREB on HNF-4α transcriptional activity is dependent on the
levels of PGC-1α. COS-1 (A, B) and HepG2 (C, D) cells were transfected with the HNF-4-
tk-luc reporter construct (0.6 μg), together with expression plasmids encoding HNF-4α
(0.05 μg), CREB (0.5 μg), PKA-Cα (0.1 μg), and PGC-1α (0.5 μg). 8-CPT-cAMP (300 μM)
(cAMP) was added 3 h after transfection. Cell lysis and luciferase assays were
performed 48 h after transfection as described in Materials and methods. Luciferase
activity is presented as the mean±SD of at least two independent experiments with
triplicate transfections.
1016 S.N. Dankel et al. / Biochimica et Biophysica Acta 1803 (2010) 1013–1019To examine whether the CREB-mediated regulation of HNF-4α
function was modulated via PGC-1α, we also transfected cells with
PGC-1α expression vector in combination with plasmid encoding
CREB. In COS-1 cells, overexpression of PGC-1α clearly counteracted
the suppressive effect of CREB on HNF-4α activity (Fig. 4B). In HepG2
cells, overexpressed CREB had no additional effect to PGC-1α
overexpression on HNF-4α activity, unless cells were also exposed
to a cAMP analog or PKA-Cα overexpression. Of note, overexpression
of CREB did not enhance the effect of PGC-1α in absence of PKA
activation (Fig. 4C and D). Taken together, the results suggest that
cAMP/PKA stimulates HNF-4α transcriptional activity in HepG2 cells
through CREB activation, likely in part through induction of PGC-1α.
Since phosphorylation of CREB by cAMP/PKA may determine its
effect on PGC-1α induction and HNF-4α transcriptional activity, we
examined whether CREB phosphorylation at serine 133 (S133) is
differential in COS-1 and HepG2 cells. In COS-1 cells, PKA-Cα
overexpression led to a marked increase in the levels of phosphor-
ylated CREB both in presence and absence of coexpressed HNF-4α
(Fig. 5A). Of interest, we observed an increased level of total CREB
after overexpression of HNF-4α, which may lead to a reduced PCREB/
Fig. 5. Serine 133-speciﬁc phosphorylation of CREB is differentially regulated in COS-1
and HepG2 cells. COS-1 (A) and HepG2 (B) cells were transiently transfected with
expression plasmid encoding CREB (1.0 μg), together with expression plasmids
encoding PGC-1α (1.0 μg) or PKA-Cα (0.2 μg), and HNF-4α (0.1 μg). Cells were lysed
and subjected to Western blotting as described in Materials and methods. Serine 133
(S133)-speciﬁc phosphorylation of CREB was detected using an antibody speciﬁcally
against S133-phosphorylated CREB (PCREB). Total CREB and GAPDH protein levels
were detected using anti-CREB and anti-GAPDH antibodies, respectively.
Fig. 6. Effect of cAMP on endogenous mRNA levels of HNF-4α target genes. HepG2 cells
were transiently transfected with CREB (1 μg) and treated with 8-CTP-cAMP (300 μM)
3 h after transfection. Cells were collected 24 h after transfection, and RNA was
extracted followed by reverse transcription. mRNA expression levels of HNF-4α (A),
PGC-1α (B), PCK1 (C) and G6Pase (D) were analysed by real-time PCR in duplex with
and relative to TBP (arbitrary units). Results are presented as the mean±SD of
duplicate transfections and are representative of two to three experiments.
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transcriptional activity in COS-1 cells was also observed in absence of
PKA activation and with low levels of phosphorylated CREB. Thus, the
negative effect of CREB appears to be independent of cAMP/PKA-
mediated CREB phosphorylation. In HepG2 cells, we observed a small
increase in the levels of phosphorylated CREB after PKA-Cα over-
expression (Fig. 5B). These ﬁndings suggest that cAMP/PKA stimu-
lates HNF-4α transcriptional activity and PGC-1α coactivator
function, at least in part, through CREB phosphorylation.
3.3. cAMP-mediated induction of HNF-4α target genes in HepG2 cells
To assess the endogenous effects of cAMP/PKA and CREB in HepG2
cells, we examined the expression levels of two HNF-4α/PGC-1α
target genes, phosphoenolpyruvate carboxykinase (PCK1) and glu-
cose-6-phosphatase (G6Pase). In addition, the mRNA levels of HNF-
4α and PGC-1α were measured after exposure to a cAMP-analog and
CREB overexpression. We observed no signiﬁcant effects by cAMP or
CREB on the expression level of HNF-4α (Fig. 6A). As expected, the
expression of PGC-1α increased upon cAMP treatment and the effect
appeared to be further simulated by CREB overexpression in
combination with cAMP exposure (Fig. 6B). Furthermore, cAMP
stimulated the expression of PCK1 and G6Pase in the HepG2 cells,
whereas overexpression of CREB alone had no signiﬁcant effect
(Fig. 6C and D). These ﬁndings are in accordance with the above
results suggesting that activation of the cAMP pathway, through
induction of PGC-1α, stimulates HNF-4α transcriptional activation in
HepG2 cells. CREB has no stimulatory effect by itself in HepG2 cells,
but depends on cAMP-dependent activation.
4. Discussion
The nuclear receptor HNF-4α is an important regulator of hepatic
metabolism [10,11]. It has previously been shown that fasting and
elevated cAMP levels reduce HNF-4α DNA binding activity in rat liver
and that HNF-4α is phosphorylated directly by PKA [16]. Yet, HNF-4α
is known to be involved in activation of several genes whose
expression increase during fasting and insulin deﬁciency, such as
genes regulating gluconeogenesis, apolipoprotein synthesis, ureagen-
esis and bile acid synthesis. The nuclear receptor function is tissue
speciﬁc and depends on the levels of coregulators. It has been shown
that the coactivator PGC-1α, whose expression and activity increase
during fasting and elevated levels of cAMP, is important for HNF-4α
activity [32].
The present study was initiated to examine the role of PGC-1α and
CREB in the cAMP-mediated regulation of HNF-4α. In accordancewithprevious studies, PGC-1α coactivated HNF-4α in both HepG2 and
COS-1 cells [33,34]. Interestingly, we observed that the cAMP/PKA
signaling pathway had a cell speciﬁc effect on HNF-4α transactivation
in the two cell types. In contrast to COS-1 cells, cAMP/PKA stimulated
the transcriptional activity of HNF-4α in HepG2 cells. Although these
results appear to contradict another report [35], it must be recognized
that cell line speciﬁc coactivator expression patterns may cause these
differences [32]. Moreover, the relative amounts of coactivator- and
nuclear receptor expression plasmids used in the transient transfec-
tion experimentsmay also determine the response [36]. In the present
study we have used low amounts of nuclear receptor expression
plasmid in order to examine the role of interacting coactivators.
Our results suggest that the observed cAMP/PKA-mediated
stimulation of HNF-4α transactivation in HepG2 cells is at least
partially explained by an increase in the levels of PGC-1α. We found
that activation of the cAMP/PKA signaling pathway stimulated the
PGC-1α mRNA expression in HepG2 cells, which is in line with a
previous study of primarymouse hepatocytes [37]. A key role for PGC-
1α in HNF-4α-mediated transactivation is moreover supported by the
ﬁnding that overexpression of PGC-1α in COS-1 cells, that contain low
levels of endogenous PGC-1α, opposed the suppressive effect of
cAMP/PKA on HNF-4α transactivation. Consistently, knock-down of
PGC-1α in HepG2 cells signiﬁcantly reduced HNF-4α-mediated
transactivation and abolished the stimulatory effect of PKA-Cα.
Taken together, our results indicate that PGC-1α is a key factor in
1018 S.N. Dankel et al. / Biochimica et Biophysica Acta 1803 (2010) 1013–1019the cAMP-mediated regulation of HNF-4α transactivation, and that
the cell line-dependent level of PGC-1α determines the HNF-4α
activity in response to cAMP/PKA.
Activation of PKA has been shown to enhance the transcription of
PGC-1α through phosphorylation and activation of CREB [28,29]. In
HepG2 cells, CREB overexpression required PKA activation in order to
stimulate HNF-4α-depedent transcription. Moreover, we found that
cAMP increased the mRNA expression of PGC-1α as well as the
endogenous HNF-4α target genes PCK1 and G6Pase in HepG2 cells.
Overexpression of CREB in absence of cAMP/PKA activation seemed
not to stimulate the expression of these genes. Thus it appears that
CREB must be activated in order to stimulate HNF-4α function via
increased expression of PGC-1α [38]. A lack of PGC-1α induction in
COS-1 cells likely contributed to the cell speciﬁc effects of cAMP/PKA
and CREB. Of particular interest, our study provides new information
on CREB-mediated regulation of HNF-4α transcriptional activity. A
previous study found a suppressive effect of cAMP/PKA on HNF-4α
DNA binding activity, possibly through phosphorylation by PKA [16].
In the present study we observed that CREB inhibited HNF-4α activity
in transiently transfected COS-1 cells similar to cAMP/PKA, regardless
of cAMP/PKA activation and CREB phosphorylation. The mechanisms
responsible for the CREB-mediated regulation of HNF-4α transcrip-
tional activity are currently unknown. We found no effect of CREB
overexpression on the HNF-4α mRNA level in the two cell types,
neither in absence nor in presence of overexpressed PKA-Cα (data not
shown). One may speculate whether CREB acts through a transcrip-
tion-independent mechanism, such as protein-protein interaction, in
order to downregulate HNF-4α function. Future studies will elucidate
the mechanisms whereby cAMP/PKA and CREB exert direct effects on
PGC-1α and HNF-4α function.
While PGC-1α induction by cAMP/PKA in HepG2 cells appears to
be an important mechanism regulating HNF-4α function, other HNF-
4-associated coactivators may also have contributed to the cell
speciﬁc effects. The p160 steroid receptor coactivator (SRC) family
comprising SRC-1, SRC-2/GRIP1 and SRC-3/AIB1 interact with HNF-
4α [21,23], and we have previously shown that the cAMP/PKA
signaling pathway downregulates the SRC-2 protein level in COS-1
cells through ubiquitin-mediated degradation [39]. Overexpression of
PKA-Cα reduced the SRC-2 protein level also in HepG2 cells, which
was associated with a reduction in SRC-2-mediated HNF-4α tran-
scriptional activity in both cell types. Thus, downregulation of
endogenous SRC-2 may represent a mechanism whereby PKA-Cα
reduced HNF-4α activity in COS-1 cells. However, PKA-Cα exerted a
similar suppressive effect on HNF-4α activity also with overexpres-
sion of SRC-1 and SRC-3 (data not shown). Since it has been shown
that PKA does not inhibit the coactivator functions of SRC-1 and SRC-3
as with SRC-2 [40], it appears that the PKA-mediated inhibition of
HNF-4α is independent of the SRCs. Furthermore, when the SRCs
were overexpressed together with low levels of PGC-1α, these
coactivators did not modulate the effects of PKA and PGC-1α on
HNF-4α (data not shown), underscoring the important role of cAMP/
PKA and PGC-1α in HNF-4α transactivation.
In the present work we present results demonstrating cell speciﬁc
effects of cAMP/PKA in regulation of HNF-4α transcriptional activity.
The level of PGC-1α is an important determinant for the effect not
only of cAMP/PKA, but also of CREB, on HNF-4α function. Our study
emphasizes the importance of evaluating endogenous levels of
coactivators in studies of nuclear receptor function in response to
intracellular signaling such as the cAMP/PKA pathway.
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